Alphagen Securities »

Five Prime Therapeutics shares owned by Alphagen Securities

Quarter-by-quarter ownership of Five Prime Therapeutics shares owned by Alphagen Securities from 13F filings

Historical chart of Alphagen Securities investment in Five Prime Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Five Prime Therapeutics held by Alphagen Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Five Prime Therapeutics by Alphagen Securities

Quarter filed Position value Share count Share price at filing
2015-09-30 $29k 1.9k 15.43
2015-06-30 $19k 750 25.33
2015-03-31 $30k 1.3k 23.08